NYMOX PHARMACEUTICAL CORP Quarterly Liabilities in USD from Q4 2015 to Q3 2023

Taxonomy & unit
ifrs-full: USD
Summary
Nymox Pharmaceutical Corp quarterly Liabilities history and growth rate from Q4 2015 to Q3 2023.
  • Nymox Pharmaceutical Corp Liabilities for the quarter ending September 30, 2023 was $2.57M, a 8.57% increase year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $2.57M +$203K +8.57% Sep 30, 2023 6-K 2023-11-15
Q2 2023 $3.15M +$906K +40.4% Jun 30, 2023 6-K 2023-08-14
Q1 2023 $2.37M -$254K -9.67% Mar 31, 2023 6-K 2023-05-12
Q4 2022 $2.11M +$158K +8.11% Dec 31, 2022 6-K 2023-11-15
Q3 2022 $2.37M +$100K +4.41% Sep 30, 2022 6-K/A 2022-11-16
Q2 2022 $2.24M +$279K +14.2% Jun 30, 2022 6-K 2022-08-15
Q1 2022 $2.63M +$1.16M +79.1% Mar 31, 2022 6-K 2022-05-13
Q4 2021 $1.95M -$249K -11.3% Dec 31, 2021 20-F 2023-05-02
Q3 2021 $2.27M +$372K +19.6% Sep 30, 2021 6-K 2021-11-12
Q2 2021 $1.96M -$156K -7.36% Jun 30, 2021 6-K 2021-08-13
Q1 2021 $1.47M -$463K -24% Mar 31, 2021 6-K 2021-05-14
Q4 2020 $2.2M +$157K +7.69% Dec 31, 2020 20-F 2022-03-30
Q3 2020 $1.9M +$84K +4.64% Sep 30, 2020 6-K 2020-11-13
Q2 2020 $2.12M +$169K +8.67% Jun 30, 2020 6-K 2020-08-14
Q1 2020 $1.93M +$219K +12.8% Mar 31, 2020 6-K 2020-05-14
Q4 2019 $2.04M +$967K +90% Dec 31, 2019 20-F 2022-03-30
Q3 2019 $1.81M +$963K +113% Sep 30, 2019 6-K 2019-11-13
Q2 2019 $1.95M +$335K +20.7% Jun 30, 2019 6-K 2019-08-14
Q1 2019 $1.71M -$287K -14.4% Mar 31, 2019 6-K 2019-05-15
Q4 2018 $1.07M -$1.16M -51.8% Dec 31, 2018 20-F 2021-03-29
Q3 2018 $849K Sep 30, 2018 6-K 2018-11-13
Q2 2018 $1.62M Jun 30, 2018 6-K 2018-08-13
Q1 2018 $2M Mar 31, 2018 6-K 2018-05-15
Q4 2017 $2.23M -$69K -3% Dec 31, 2017 20-F 2020-03-30
Q4 2016 $2.3M -$761K -24.9% Dec 31, 2016 20-F 2019-03-29
Q4 2015 $3.06M Dec 31, 2015 20-F 2018-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.